Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Decrease serum erythropoietin level induced by iron replacement therapy in patients with iron deficiency anemia].

Y Takahashi1, H Umadome

  • 1Department of Internal Medicine, Takatsuki Red Cross Hospital.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|June 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Increased erythron transferrin uptake associated with ineffective erythropoiesis in iron deficiency state--the common factors to iron deficiency anemia and portal hypertensions].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1998
Same author

Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Japanese circulation journal·1997
Same author

[Ferrokinetics].

Nihon rinsho. Japanese journal of clinical medicine·1997
Same author

[Erythron transferrin uptake--a new refind parameter to assess erythropoietic activity].

Nihon rinsho. Japanese journal of clinical medicine·1997
Same author

[Heterogeneity of ineffective erythropoiesis in myelodysplastic syndromes evaluated by application of newly devised parameters based on ferroerythrokinetic data].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1997
Same author

[A quantitative parameter of ineffective erythropoiesis deduced by canonical discrimination and axis rotation on the basis of ferroerythrokinetic data].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1995
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Recent advances in management of systemic AL amyloidosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same journal

[Treatment strategies for relapsed or refractory multiple myeloma: proposals for optimal treatment sequencing].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
See all related articles

Iron deficiency anemia (IDA) patients show altered erythropoietin (EP) levels during iron therapy. The study reveals how iron replacement impacts the relationship between EP and hemoglobin (Hb), highlighting EP upregulation and subsequent downregulation.

Area of Science:

  • Hematology
  • Endocrinology
  • Anemia Research

Context:

  • Investigating iron deficiency anemia (IDA) patients undergoing iron replacement therapy.
  • Examining the dynamic relationship between serum erythropoietin (EP) and hemoglobin (Hb) concentrations.
  • Understanding how iron therapy modifies EP-Hb interactions.

Purpose:

  • To elucidate the changes in the EP-Hb relationship induced by iron replacement therapy in IDA patients.
  • To quantify the impact of iron deficiency severity on EP levels.
  • To analyze the temporal sequence of EP changes during treatment and relapse.

Summary:

  • Serum erythropoietin (EP) levels were assessed in 123 IDA patients before and during iron therapy using logarithmic regression.
  • Deviations in EP from predicted levels (delta-EP) were observed, particularly during the reticulocyte crisis, correlating with pretreatment iron deficiency (ID) severity.

Related Experiment Videos

  • EP upregulation was found to be significantly influenced by the ID state, with therapy-induced changes showing distinct patterns in improvement and relapse phases.

    • Impact:

    • Reveals that iron deficiency significantly upregulates erythropoietin beyond what hemoglobin deficit alone would suggest.
    • Demonstrates a therapy-induced overshooting drop in EP due to acute uptake by erythroid precursors.
    • Provides insights into erythropoietic regulation, suggesting appropriate EP downregulation to prevent excessive hemoglobin production post-treatment.